Tag: Neuropharmacology Award

Guolin Ma | Neuroscience | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Guolin Ma
Affiliation China-Japan Friendship Hospital
Country China
Scopus ID 37004529100
Documents 138
Citations 1,661
h-index 23
Subject Area Radiology, Medical Imaging, AI in Healthcare, Neuroscience
Event World Science Awards

Guolin Ma
China-Japan Friendship Hospital, China

Guolin Ma is a Chinese physician-scientist, radiologist, educator, and academic leader recognized for his extensive contributions to neuroradiology, artificial intelligence in medical imaging, radiomics, and functional magnetic resonance imaging. Serving as Chief Physician at the China-Japan Friendship Hospital and holding professorial appointments at several leading medical institutions, he has contributed significantly to advancing precision medicine through interdisciplinary imaging research and translational clinical applications.[1]

Over a career spanning more than four decades, Dr. Ma has participated in national research initiatives, supervised graduate students, developed imaging standards, secured patents, and published extensively in international scientific journals. His work integrates advanced imaging technologies, biomedical engineering, neuroscience, and artificial intelligence to improve diagnosis and understanding of neurological, psychiatric, and systemic diseases.[1]

Abstract

Guolin Ma has established a distinguished career in radiological sciences, combining clinical expertise with innovative biomedical imaging research. His scientific contributions encompass functional MRI, multimodal neuroimaging, radiomics, imaging genomics, and artificial intelligence-assisted diagnostic systems. Through leadership of national research programs and participation in major scientific initiatives, he has contributed to the advancement of imaging-based precision medicine and evidence-driven healthcare innovation. His academic activities include publication of scientific literature, supervision of postgraduate researchers, development of professional standards, and promotion of interdisciplinary medical imaging technologies.[1]

Keywords

Medical Imaging, Radiology, Neuroradiology, Functional MRI, Artificial Intelligence, Radiomics, Imaging Genomics, Neuroimaging, Precision Medicine, Brain Imaging, Quantitative Imaging, Biomedical Engineering, Diagnostic Imaging, MRI Technologies, Healthcare Innovation.

Introduction

The rapid evolution of medical imaging technologies has transformed disease diagnosis, treatment planning, and clinical decision-making. Researchers who integrate advanced imaging modalities with computational intelligence have become increasingly important contributors to modern healthcare systems. Among these scholars, Guolin Ma has developed a multidisciplinary research portfolio focused on imaging science, artificial intelligence, neuroscience, and translational medicine.[1]

His academic journey encompasses clinical practice, scientific leadership, international collaboration, and public health administration. These diverse experiences have enabled him to contribute to both fundamental imaging research and practical healthcare applications across multiple disease domains.[1]

Research Profile

Ma obtained his doctoral degree in Imaging and Nuclear Medicine from Peking Union Medical College and completed international academic training as a Visiting Scholar and Postdoctoral Researcher at the University of California, San Diego. He currently serves as Chief Physician in the Department of Radiology at the China-Japan Friendship Hospital while maintaining professorial and doctoral supervisory responsibilities at several leading Chinese medical universities.[1]

  • Chief Physician, Department of Radiology, China-Japan Friendship Hospital.
  • Professor and Doctoral Supervisor at Peking University Health Science Center.
  • Professor and Doctoral Supervisor at Peking Union Medical College.
  • Professor and Doctoral Supervisor at Capital Medical University.
  • Former health administration leader at provincial and municipal government agencies.

Research Contributions

The research contributions of Ma span clinical radiology, biomedical engineering, neuroscience, and artificial intelligence. His investigations have focused on the development and application of advanced imaging methodologies for diagnosing and understanding neurological, psychiatric, and head and neck disorders.[2]

  • Leadership of National Key Research and Development Program projects.
  • Principal investigator of multiple National Natural Science Foundation of China projects.
  • Development of AI-based precision diagnostic imaging systems.
  • Multimodal MRI investigations of Alzheimer’s disease and schizophrenia.
  • Research on Bell’s palsy, autism spectrum disorder, and cerebrovascular diseases.
  • Advancement of imaging genomics and radiomics methodologies.
  • Contributions to medical imaging standards and software innovations.

Publications

Ma has authored more than one hundred scientific publications, including over eighty papers indexed in major international citation databases. His scholarly output includes original research articles, review papers, book chapters, translated academic texts, and technical contributions related to neuroimaging and diagnostic radiology.[1]

  • More than 100 peer-reviewed scientific publications.
  • Over 80 SCI-indexed articles.
  • Author and translator of six academic books.
  • 28 invention patents filed or granted.
  • Four software copyrights.
  • Contributor to five professional imaging standards.

Representative scholarly areas include functional MRI data analysis, resting-state functional connectivity, quantitative neuroimaging, and artificial intelligence-assisted radiological assessment.[3]

Research Impact

The impact of Ma’s work extends beyond academic publication to clinical implementation, educational leadership, and healthcare policy development. His investigations have improved understanding of neurological and psychiatric disorders through imaging biomarkers, brain network analysis, and advanced MRI methodologies. Furthermore, his efforts in artificial intelligence and quantitative imaging have contributed to emerging precision healthcare strategies and intelligent diagnostic systems.[1]

As a mentor, he has supervised doctoral and master’s students who continue to contribute to radiological sciences and biomedical research. His editorial service and participation in national scientific review panels further demonstrate his influence within the international imaging research community.[1]

Award Suitability

Guolin Ma demonstrates strong qualifications for recognition within international medical imaging and healthcare innovation award programs. His combination of scientific productivity, research leadership, educational contributions, technological innovation, and clinical impact reflects sustained excellence in radiological sciences.[1]

  • Internationally recognized expertise in neuroradiology and neuroimaging.
  • Leadership of nationally funded research initiatives.
  • Extensive publication and patent portfolio.
  • Significant contributions to AI-enabled healthcare technologies.
  • Academic mentorship and scientific leadership.
  • Contributions to healthcare standards and translational medicine.

Conclusion

Guolin Ma has established a distinguished record of achievement in radiology, neuroimaging, artificial intelligence, and translational medical research. Through scientific innovation, educational leadership, clinical excellence, and national service, he has contributed substantially to the advancement of modern medical imaging sciences. His continued efforts in precision medicine and intelligent healthcare technologies position him among the notable contributors to contemporary radiological research and biomedical innovation.[1]

References

  1. Professional biography and curriculum vitae of Professor Guolin Ma, China-Japan Friendship Hospital, Peking University Health Science Center, and affiliated academic institutions.
  2. Elsevier. (n.d.). Scopus Author Details: Guolin Ma, Author ID 37004529100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37004529100
  3. Digital Object Identifier Foundation. (n.d.). DOI Registry and Scholarly Reference Infrastructure.

Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Published on by World Science Awards

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes

  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Farsin Hamzei | Neuroscience | Best Researcher Award

Published on by World Science Awards

Prof. Dr. Farsin Hamzei | Neuroscience | Best Researcher Award

Lecture from Moritz Klinik, Germany

Prof. Dr. med. Farsin Hamzei is a highly accomplished neurologist and researcher specializing in neurorehabilitation. With over two decades of experience in academic and clinical neurology, he has significantly contributed to stroke rehabilitation, motor network recovery, and non-invasive brain stimulation techniques. Currently, he serves as the Chief Physician at Moritz Klinik Bad Klosterlausnitz and holds a professorship at Friedrich-Schiller-Universität Jena. His leadership has driven the expansion of rehabilitation services, including the establishment of specialized outpatient centers for neurological recovery. He has received prestigious research grants and awards, highlighting his contributions to innovative therapeutic approaches. His expertise spans functional MRI, transcranial magnetic stimulation (TMS), and diffusion tensor imaging, advancing the understanding of neural plasticity. Prof. Hamzei has also played a vital role in medical education, mentoring students and professionals in neurology and neurorehabilitation. His work is recognized both nationally and internationally, with a focus on improving patient outcomes through cutting-edge research. His leadership in clinical and research settings, along with his dedication to advancing neurorehabilitation, has made him a key figure in the field. His ongoing research aims to refine therapeutic strategies and enhance the effectiveness of rehabilitation for stroke and neurological disorders.

Professional Profile

Education

Prof. Hamzei pursued his medical studies at multiple prestigious German universities. He began his medical education at Johann Wolfgang Goethe University in Frankfurt (1989-1992), where he completed his preliminary medical examination. He continued at Ruprecht-Karls-Universität Heidelberg-Mannheim (1992-1993) and later at Rheinische Friedrich-Wilhelms-Universität Bonn (1993-1995), where he successfully completed his final medical examinations. In 1996, he finished his practical training in oncology, cardiovascular surgery, and neurology at the University Hospital Bonn. He obtained his medical degree and licensure in November 1996. His academic journey also includes a Doctor of Medicine (M.D.) degree awarded in 1997 for his dissertation on cortisol concentration changes in patients with obsessive-compulsive disorder. He later achieved his habilitation in neurology in 2006, focusing on functional studies of motor network organization. Furthering his education in healthcare administration, he obtained a Master of Health Business Administration (MHBA) between 2012 and 2014, equipping him with leadership skills in hospital management and healthcare economics. His comprehensive education in medicine, research, and business administration has enabled him to lead and innovate in neurological rehabilitation, integrating clinical expertise with advanced research methodologies.

Professional Experience

Prof. Hamzei has an extensive career in neurology, research, and medical leadership. He began as a physician in training at the Neurological University Hospital Bonn in 1997. From 1999 to 2000, he received a prestigious research fellowship from the German Research Foundation (DFG) at the Neurological University Hospital Jena. Between 2001 and 2005, he worked as a research associate at the Neurological University Hospital Hamburg-Eppendorf, further developing his expertise in neuroimaging and neurorehabilitation. In 2005, he became a board-certified neurologist and subsequently joined the Neurological University Hospital Freiburg as a senior research associate. By 2007, he was appointed Senior Consultant at the same institution. His academic career flourished when he received the venia legendi for neurology in 2006 and later a professorship in Neurological Rehabilitation at Friedrich-Schiller-Universität Jena in 2009. Since 2010, he has been the Chief Physician of the Neurological Department at Moritz Klinik Bad Klosterlausnitz, where he has led expansions in rehabilitation services. His leadership extends to directing specialized centers, including those for aphasia, dysphagia, and long-COVID therapy. His career reflects a strong balance of clinical practice, research, and medical education.

Research Interests

Prof. Hamzei’s research focuses on neurorehabilitation, motor recovery after stroke, and neural plasticity. He investigates how the brain reorganizes itself following central nervous system damage, using advanced imaging and stimulation techniques. His work explores the adaptation and functional restoration of motor networks post-injury, employing tools like functional MRI, transcranial magnetic stimulation (TMS), and diffusion tensor imaging (DTI). He is particularly interested in training-based changes in the brain, examining how therapies like forced-use therapy, video-assisted rehabilitation, and mirror therapy impact motor recovery. Another key area of his research is non-invasive brain stimulation, including repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS), to enhance neuroplasticity and functional improvement in patients. He also investigates cognitive and motor training for neurorehabilitation, aiming to develop innovative therapies for stroke and neurodegenerative conditions. His research integrates neuroscience, technology, and clinical application, focusing on improving patient outcomes through personalized rehabilitation strategies. Additionally, he collaborates on projects related to aphasia and long-COVID rehabilitation, expanding the scope of his expertise. His contributions have significantly influenced rehabilitation protocols and the understanding of motor network reorganization in patients with neurological disorders.

Research Skills

Prof. Hamzei possesses extensive expertise in neuroimaging and neuromodulation techniques for neurorehabilitation research. He is proficient in functional MRI (fMRI), diffusion tensor imaging (DTI), and voxel-based morphometry, which he uses to analyze brain network reorganization. His skills extend to transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), tools that he employs to investigate and enhance neuroplasticity in patients with motor deficits. He has experience in clinical trial design, having led and contributed to numerous studies evaluating rehabilitation techniques for stroke and neurological disorders. His methodological expertise includes randomized controlled trials (RCTs) and observational studies in neurorehabilitation. Additionally, he is skilled in data analysis and interpretation of neural connectivity changes post-rehabilitation. His research funding achievements demonstrate his ability to secure grants and manage large-scale scientific projects. He also has experience in interdisciplinary collaboration, working with neurologists, physiotherapists, and psychologists to develop innovative rehabilitation approaches. His ability to integrate cutting-edge neuroscience with clinical applications highlights his effectiveness as both a researcher and a clinician. His technical and analytical skills in neurorehabilitation research have contributed to advancements in understanding and treating motor impairments after neurological injury.

Awards and Honors

Prof. Hamzei has received multiple awards in recognition of his contributions to neurorehabilitation research. In 2009, he was awarded the Fritz und Eleonore Hodeige Prize for his development of innovative therapeutic approaches in neurological rehabilitation. This award highlighted his impact on improving rehabilitation techniques for patients recovering from neurological injuries. In 2016, he received third place in the Reha Zukunftspreis from IQMG and BDPK for his work on the “Model-A-Team” in neurological rehabilitation. This recognition was for pioneering a collaborative, interdisciplinary approach to patient recovery. Beyond these prestigious awards, he has consistently received research funding from national and international organizations, including the European Network for Excellence (FP6) and the Bernstein Network for Neurotechnology, which provided over €1 million for his research. His ability to secure major grants further demonstrates his excellence in research and innovation. He has also been appointed to multiple examination committees in Germany, solidifying his influence in shaping future generations of neurologists. These honors reflect his dedication to advancing neurological rehabilitation, integrating research with clinical applications to improve patient care and outcomes.

Conclusion

Prof. Dr. med. Farsin Hamzei is a leading expert in neurorehabilitation, with a distinguished career in academic research, clinical practice, and medical education. His extensive contributions to stroke recovery, motor network adaptation, and non-invasive brain stimulation have significantly advanced the field. Through his leadership at Moritz Klinik and Friedrich-Schiller-Universität Jena, he has expanded rehabilitation services and integrated innovative therapeutic approaches. His research, supported by prestigious grants and awards, focuses on enhancing neuroplasticity and functional recovery through cutting-edge imaging and stimulation techniques. His expertise in neuroimaging, clinical trials, and interdisciplinary collaboration has strengthened rehabilitation strategies for neurological patients. His commitment to education, serving on medical examination boards and mentoring future neurologists, further underscores his influence in the field. Prof. Hamzei’s dedication to improving patient outcomes through research, innovation, and education positions him as a key figure in neurorehabilitation. His continued work will likely shape the future of rehabilitation medicine, advancing both theoretical understanding and practical applications for neurological recovery.

Publications Top Notes

  1. Title: Implicit Motor Learning Under Anodal or Cathodal tDCS During fMRI Induces Partially Distinct Network Responses
    Authors: Farsin Hamzei, Alexander Ritter, Daniel Güllmar
    Year: 2025

  2. Title: A Randomized Controlled Trial to Test the Effects of Repetitive Peripheral Magnetic Stimulation Versus Neuromuscular Electrical Stimulation in Patients with Spastic Hemiparesis After Stroke (REPMAST): Study Protocol
    Authors: Kristin Loreen Pohl, Jens Müller, Katja Wittig-Böttger, Alexander Ritter, Farsin Hamzei
    Year: 2024

  3. Title: Different Effect Sizes of Motor Skill Training Combined with Repetitive Transcranial versus Trans-Spinal Magnetic Stimulation in Healthy Subjects
    Authors: Farsin Hamzei, Alexander Ritter, Kristin Pohl, Peggy Stäps, Eric Wieduwild
    Year: 2024

  4. Title: Understanding the concept of a novel tool requires interaction of the dorsal and ventral streams
    Authors: Gundula Seidel, Michel Rijntjes, Daniel Güllmar, Cornelius Weiller, Farsin Hamzei
    Year: 2023

  5. Title: Accelerated brain ageing in sepsis survivors with cognitive long‐term impairment
    Authors: Gundula Seidel, Christian Gaser, Theresa Götz, Albrecht Günther, Farsin Hamzei
    Year: 2020

  6. Title: Anatomy of brain lesions after stroke predicts effectiveness of mirror therapy
    Authors: Farsin Hamzei, Gabriele Erath, Ursula Kücking, Cornelius Weiller, Michel Rijntjes
    Year: 2020